Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The E6 protein is an oncoprotein encoded by high-risk human papillomavirus (HPV) types, notably HPV-16 and HPV-18. It plays a central role in the induction and maintenance of cellular transformation, contributing directly to the development of cervical cancer and other HPV-associated malignancies. E6 is essential for viral replication, persistence of infection, and evasion of host cell defenses. The hallmark function of high-risk HPV E6 is targeting the tumor suppressor p53 for ubiquitin-mediated proteasomal degradation and interacts with other cellular targets.
Disrupt E6 interaction with E6AP/p53; Inhibit E6 interaction with PDZ domain proteins; Block E6-mediated apoptosis inhibition; Target E6 for degradation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Protein E6 (E6).